• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 178
  • 28
  • 22
  • 18
  • 16
  • 13
  • 9
  • 6
  • 3
  • Tagged with
  • 381
  • 381
  • 55
  • 50
  • 47
  • 41
  • 38
  • 36
  • 36
  • 33
  • 30
  • 29
  • 27
  • 26
  • 24
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
261

Rolle der Histonmethyltransferase Suv39h1 in zellulärer Seneszenz und Ras-induzierter Lymphomgenese

Braig, Melanie 13 December 2007 (has links)
Apoptose und Seneszenz sind stress-responsive, genetisch verankerte „Failsafe“- Mechanismen, welche die Zelle vor maligner Transformation schützen. Onkogenes Ras induziert zelluläre Seneszenz über den p16/Retinoblastoma (Rb)-Signalweg und führt dabei zu einem permanenten Zellzyklusarrest - das tumorsuppressive Potential von Seneszenz in vivo bleibt jedoch bis heute fraglich. In seneszenten Zellen ist die Expression von S-Phase relevanten Gene durch die lokale Ausbildung von Heterochromatin, bzw. der Methylierung von Histon H3 an Lysin 9 (H3K9me) blockiert. Dies lässt vermuten, dass Seneszenz ein epigenetische kontrollierter Prozess ist und von Proteinen wie der Rb-assozierte Histonmethyltransferase Suv39h1 reguliert wird. In der vorliegenden Arbeit konnte gezeigt werden, dass Eµ-N-Ras transgene Mäuse mit heterozygoten Läsionen im Suv39h1 oder p53 Lokus aggressive T-Zell Lymphome entwickeln, die gegen Suv39h1, bzw. p53-Expression selektieren. Im Gegensatz dazu entwickeln N-Ras-transgene Wildtyp-Tiere („Kontrollen“) vorrangig nicht-lymphoide Tumoren und sterben signifikant später. In primären Lymphozyten induziert onkogenes Ras einen Suv39h1-abhängigen, H3K9me-assoziierten Proliferationsarrest und kann dadurch Lymphomgenese verhindern. Suv39h1-defiziente Lymphomzellen wachsen exponentiell und sind, entgegen p53 defizienten Zellen, sensitiv gegenüber Adriamycin-induzierten Zelltod (Apoptose). Jedoch arretieren nur Kontroll-Lymphome unter Therapie in vitro wenn Apoptose blockiert ist, nicht aber Suv39h1 oder p53-defiziente Lymphomzellen. Diese Resultate identifizieren Ras-induzierte Seneszenz als einen neuen, H3K9me-abhängigen Tumorsuppressor-Mechanismus, wobei dessen Inaktivierung die Entwicklung von aggressiven, aber dennoch Apoptose-kompetenten Lymphomen herbeiführt. / Cellular “failsafe” programs like apoptosis or senescence are genetically encoded, stress-responsive mechanisms that ultimately counteract malignant transformation. Acute induction of oncogenic Ras provokes cellular senescence that involves the p16/Retinoblastoma (Rb) pathway to induce a permanent arrest, but the tumor suppressive mechanism in vivo still remains questionable. Senescent cells display heterochromatic features on S-phase relevant genes involving methylation of histone H3 on lysine 9 (H3K9me), which may depend on the Rb-associated histone methyltransferase Suv39h1. In the present thesis it was shown that Eµ-N-Ras transgenic mice harboring targeted heterozygous lesions at the Suv39h1, or the p53 locus for comparison, succumb to invasive T cell lymphomas that lack expression of Suv39h1 or p53, respectively. By contrast, most N-Ras-transgenic wildtype (“control”) animals develop a non-lymphoid neoplasia significantly later. Proliferation of primary lymphocytes is directly stalled by a Suv39h1-dependent, H3K9me-related senescent growth arrest in response to oncogenic Ras, thereby cancelling lymphomagenesis at an initial step. Suv39h1-deficient lymphoma cells grow rapidly but, unlike p53-deficient cells, remain highly susceptible to adriamycin-induced apoptosis. In contrast, only control, but not Suv39h1-deficient or p53-deficient lymphomas senesce after drug therapy when apoptosis is blocked. These results identify H3K9me-mediated senescence as a novel Suv39h1-dependent tumour suppressor mechanism whose inactivation permits the formation of aggressive but apoptosis-competent lymphomas in response to oncogenic Ras.
262

Proteomanalyse eines Mausmodells für die Alzheimer-Krankheit

Hartl, Daniela 23 February 2009 (has links)
Im Zentrum der vorliegenden Arbeit steht die Proteomanalyse des APP23-Mausmodells für die Alzheimer-Krankheit (AK). Es wurden die Gehirnregionen Hippocampus und Cortex der Altersstadien Embryonaltag 16 sowie 1, 2, 7 und 15 Monate untersucht und somit erstmals eine Art „Proteom-Lebensprofil“ eines Mausmodells erstellt. Bei dem Vergleich der APP23-Mäuse mit Wildtypmäusen konnte innnerhalb aller untersuchten Altersstadien und Gehirnregionen eine große Anzahl quantitativer Proteinexpressionsunterschiede festgestellt werden. Interessanterweise bestand jedoch im Hippocampus adoleszenter, zwei Monate alter Mäuse, ein herausragend großer Unterschied. Ein Vergleich der Proteomzusammensetzung zwischen den verschiedenen Altersstadien zeigte, dass spezifisch im Hippocampus der adoleszenten APP23-Mäuse viele entwicklungsbedingte Proteomveränderungen ausgeblieben waren. Zusammen mit der Beobachtung, dass in diesem Altersstadium viele synaptische Proteine in den APP23-Mäusen herunterreguliert waren, weisen die gewonnenen Daten darauf hin, dass ein natürlicher Peak in der hippocampalen Plastizität während der Adoleszenzphase in den APP23-Mäusen ausgeblieben war. Es ist weiterhin bekannt, dass APP als auch eine wichtige Rolle in der embryonalen Neurogenese spielt. Da über diese Prozesse noch wenig bekannt ist, wurde im Rahmen der vorliegenden Studie weiterhin eine grundlegende Untersuchung der murinen embryonalen Gehirnentwicklung durchgeführt. Dabei wurde beobachtet, dass innerhalb eines Zeitraums von zwei Entwicklungstagen die Anzahl an quantitativ veränderten Proteinen konstant ist. Dies könnte die maximal mögliche Veränderungsrate wiederspiegeln, die wiederum einen begrenzenden Faktor für die Geschwindigkeit der Embryonalentwicklung darstellt. Weiterhin stieg im Zuge der Neurogenese die Konzentration zelltypspezifischer Proteine an während im Gegenzug die Konzentration unspezifischer Proteine abnahm. / The work presented here focuses on the analysis of the APP23 mouse model for alzheimer´s disease (AK). Using a proteomics approach; the two brain regions cortex and hippocampus, were analyzed at the ages 1,2,7 and 15 months and at embryonic day 16. Thus, for the first time, a lifetime profile of brain proteome alterations caused by mutant APP expression was created. Protein expression alterations between APP23 and control mice were numerous at all age stages but unexpectedly, the hippocampus of two-month old (adolescent) mice, showed a dramatic peak in the number of altered proteins. When comparing proteome patterns longitudinally between age-stages, protein alterations were largely absent in the hippocampus of adolescent APP23-mice but not in other stages compared. Apparently, the large difference in hippocampal protein pattern changes between two-month old APP23- and wildtype-mice was caused by an absence of distinct developmental changes in APP23-mice. In summary, the absence of longitudinal developmental proteome alterations during adolescence, a developmental stage where neuronal plasticity is prominent and horizontal (disease/control) down-regulation of many proteins related to plasticity suggests the disruption of a normally occurring peak of hippocampal plasticity during adolescence of APP23-mice. APP was also suggested to play an important role in embryonic neurogenesis. Since information about the molecular mechanisms of neurogenesis is scarce, a basic analysis of protein changes during normal embryonic neurogenesis was conducted. Interestingly, the rate of protein concentration change within two days of development was constant. This might represent the maximal rate limiting the speed of embryonic development. During neurogenesis, cell-type specific proteins were up- and unspecific proteins down-regulated. In summary, this study shows that it is of utmost importance to investigate AK even at an early age prior to the occurrence of disease symptoms.
263

Estudo da imunogenicidade de antígenos de Neisseria meningitidis: utilização de toxóide como adjuvante, vetorizado em lipossomas, no modelo camundongo. / Neisseria meningitidis antigens immune response study: toxoid as mice model adjuvant encapsulated in liposomes.

Cunha, Tulio Nakazato da 09 December 2008 (has links)
N.meningitidis é diplococcus gram-negativo, patógeno estritamente humano que similarmente a outras bactérias é circundado por membrana externa, com lipídios, proteínas (OMP) e lipopolissacárides. Ela tem sido uma das principais causas da meningite e de outras infecções invasoras no mundo. Este trabalho buscou usar o toxóide STX2 de E.coli como adjuvante para um possível e futuro modelo vacinal e como estimulante antigênico, proteínas da membrana externa do meningococo (OMP) transportados em lipossomas. Observaram-se diferenças na produção de anticorpos IgG obtidas entre os camundongos após cada uma das 3 sangrias mas, não quanto ao índice de avidez. A nova preparação antigênica desencadeou um alto título, mesmo após um ano da 1ª imunização, estimulou a produção de anticorpos para outros sítios de ligação e serviu como proteção ao LPS residual dos processos com deoxicolato da OMP, diminuindo toxicidade da preparação IM reduzindo os riscos para idosos e crianças muito pequenas e também, em imunizações de longo termo, com grande vantagem aos sistemas tradicionais. / N.meningitidis is diplococcus gram-negative strict human patogen that similarly to other bacteria are surrounded by external membrane with lipids, proteins (OMP) and LPS. It has been one of the main causes of the meningitidis and other invading infections in the world. This work searched to use STX2 toxoid of E.coli as adjuvant for a possible and future vaccine model and as antigenic stimulant proteins of the external membrane of meningococci (OMP) carried in liposomes. Differences in the production of IgG antibodies gotten between the mice each one of the 3 bleedings had been observed after but not how much to the avidity index. The new antigenic preparation unchained one high heading exactly after one year of 1st immunization stimulated the production of antibodies for other sites of linking and served as protection to the residual LPS of the processes with deoxicolate of the OMP diminishing toxicity of IM preparation reducing the aged risks for and very small children e also, in immunizations of long term with great advantage to the traditional systems.
264

Efeitos da defici?ncia de vitamina D na fun??o pulmonar de um modelo de asma al?rgica experimental

Nu?ez, Nail? Karine 12 July 2017 (has links)
Submitted by PPG Pediatria e Sa?de da Crian?a (pediatria-pg@pucrs.br) on 2018-02-16T19:15:31Z No. of bitstreams: 1 Tese final 2018 - artigo publicado.pdf: 1647298 bytes, checksum: 03a39af4be2d469330c9618fb70f9cdd (MD5) / Approved for entry into archive by Caroline Xavier (caroline.xavier@pucrs.br) on 2018-02-23T16:28:05Z (GMT) No. of bitstreams: 1 Tese final 2018 - artigo publicado.pdf: 1647298 bytes, checksum: 03a39af4be2d469330c9618fb70f9cdd (MD5) / Made available in DSpace on 2018-02-23T16:35:09Z (GMT). No. of bitstreams: 1 Tese final 2018 - artigo publicado.pdf: 1647298 bytes, checksum: 03a39af4be2d469330c9618fb70f9cdd (MD5) Previous issue date: 2017-07-12 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior - CAPES / Background: Asthma is a chronic disease of the airways, characterized by bronchial inflammation and hyperresponsiveness, which affects approximately 300 million people around the world. The increase in the prevalence of asthma in recent years has been associated with an increase in vitamin D deficiency. About 1 billion people in the world have insufficient levels of vitamin D due to many factors such as reduced outdoor activities, sunscreens use and a diet low in vitamin D. In addition, many studies suggest that vitamin D deficiency has a direct effect on lung function, leading to changes in the structure of the airways and in the inflammatory process. Objectives: To evaluate the effect of vitamin D deficiency at different life stages in a murine model of allergic airways disease house dust mite (HDM) induced on inflammation and lung function. Methods: Female BALB / c mice were placed in a diet replete or deficient in vitamin D at three-week old. At 8 weeks, females were mated with males on a diet replete in vitamin D. At birth, pups were cross-fostered to assess the effects of vitamin D deficiency at different stages of life, in utero (Vit D -/+), postnatal (Vit D +/-) and whole-life (Vit D - / -) compared to the control group whole-life vitamin D replete (Vit D + / +). At 8 weeks of age, mice of both sexes were challenged for 10 consecutive days intranasally with either HDM extract or saline solution after mild anesthesia. The animals were anesthetized for lung function test and then submitted to euthanasia for bronchoalveolar lavage (BAL) and lung tissue removal 24 hours after the last intranasal challenge. The total BAL cell count and collagen quantification of lung tissue homogenized were evaluated. Results: Vitamin D deficiency did not affect HDM-induced inflammation, which was characterized by BAL eosinophilia. Vitamin D deficiency at any life stage (in utero, postnatal and all life) caused impairment of lung function, increased tissue damping and tissue elastance, being particularly observed in females. On the other hand, the asthma HDM-induced decreased airway distensibility, but only in females and vitamin D do not altered this response. Conclusion: Our results suggest that vitamin D and HDM have different mechanisms that influence in the development of allergic lung disease and furthermore the effects appear to be sex-specific. / Introdu??o: A asma ? uma doen?a cr?nica das vias a?reas, caracterizada por inflama??o e hiperresponsividade br?nquica, que atinge aproximadamente 300 milh?es de pessoas ao redor do mundo. O aumento da preval?ncia da asma nos ?ltimos anos tem sido associado ao aumento da defici?ncia de vitamina D. Cerca de 1 bilh?o de pessoas no mundo apresenta n?veis insuficientes de vitamina D em fun??o de diversos fatores, tais como a redu??o de atividades ao ar livre, uso de protetor solar e dieta pobre em vitamina D. Al?m disso, estudos sugerem que a defici?ncia de vitamina D possui um efeito direto na fun??o pulmonar, causando altera??es na estrutura das vias a?reas e no processo inflamat?rio. Objetivo: Avaliar o efeito da defici?ncia de vitamina D em diferentes est?gios da vida de camundongos com asma induzida por ?caro domiciliar (house dust mite; HDM) sobre a inflama??o e fun??o pulmonar. M?todos: Camundongos BALB/c f?meas receberam dieta rica ou deficiente em vitamina D a partir da terceira semana de vida. Com 8 semanas de vida, as f?meas foram acasaladas com machos em dieta rica em vitamina D. Ao nascimento foi realizado o cross-fostering (ado??o cruzada) com a prole para que fosse poss?vel avaliar o efeito da defici?ncia de vitamina D em diferentes est?gios da vida, in utero (Vit D -/+), p?s-natal (Vit D +/-) e durante toda a vida (Vit D -/-), em compara??o ao grupo controle, que recebeu dieta rica em vitamina D durante toda a vida (Vit D +/+). Com 8 semanas de vida, camundongos de ambos os sexos foram desafiados por 10 dias consecutivos por via intranasal, com extrato de HDM ou apenas solu??o salina. Os animais foram anestesiados para a realiza??o do teste de fun??o pulmonar e ent?o submetidos a eutan?sia para a realiza??o do lavado broncoalveolar (LBA) e retirada do tecido pulmonar, 24 horas ap?s o ?ltimo desafio intranasal. Foi avaliada a contagem total de c?lulas do LBA e quantifica??o de col?geno no homogeneizado de tecido pulmonar. Resultados: A defici?ncia de vitamina D n?o afetou a inflama??o induzida por HDM, que foi caracterizada por eosinofilia no LBA. A defici?ncia de vitamina D em qualquer fase da vida dos camundongos (in utero, p?s-natal e durante toda a vida) causou uma piora na fun??o pulmonar, aumentando o tissue damping e tissue elastance, sendo observado particularmente em f?meas. Por outro lado, a asma induzida por HDM diminuiu a distensibilidade das vias a?reas apenas em f?meas e a vitamina D n?o alterou essa resposta. Conclus?o: Nossos resultados sugerem que a vitamina D e HDM possuem diferentes mecanismos que influenciam no desenvolvimento da doen?a pulmonar al?rgica e, al?m disso, os efeitos parecem ser dependentes do sexo.
265

Investigation of the cell biology of human regulatory T cells in the context of transplantation

Milward, Kate January 2016 (has links)
Regulatory T cells (Tregs), lymphocytes that suppress immunological reactions, are of great interest for our comprehension of basic immunology and as a therapeutic agent to treat immune-mediated pathologies. Understanding the physiology of these cells will help to inform clinical strategies targeting Tregs. In order to study the homing of human Tregs, we utilised genetic engineering to drive expression of fluorescent protein in human Tregs, permitting in vivo cell tracking. We optimised a protocol for lentivirus-mediated transduction of human Tregs during in vitro expansion, to generate high yields of stably-engineered cells. After infusing labelled cells into a humanised mouse model of skin allotransplantation, we detected human Tregs within a human skin graft by PCR and visualised Tregs moving in the graft, in a live mouse, by two-photon microscopy. Through reverse genetic analyses, we explored molecular mechanisms that allow Tregs to respond adaptively to environmental cues. Neuropilin-1 (NRP1), a transmembrane co-receptor, has been implicated in the function of mouse Tregs. Tregs transduced with shRNA to knock down NRP1 were severely impaired in their capacity to suppress cell proliferation in vitro and to prolong allograft survival in a humanised mouse model. qRT-PCR analysis revealed that transcription the gene encoding the anti-inflammatory cytokine IL-10, and the autophagy-associated genes BECN1, COPS4 and MAP1LC3B, was significantly diminished in NRP1-deficient Tregs. We concluded that in human Tregs, NRP1 is necessary for suppressive function, most likely via regulation of NRP1-dependent regulation of cytokine production and metabolism. Having identified a molecular target via which Treg function might be potentiated, we explored methods to target such molecules for cell therapy applications. Tregs engineered to over-express IL-10, but not NRP1, exerted significantly enhanced suppression of cell proliferation in vitro. Thus, relatively straightforward genetic engineering, compatible with generation of therapeutic cell yields, could be exploited to improve the efficacy of Treg cellular therapy.
266

The central regulation of blood pressure and salt appetite by brain 11β- hydroxysteroid dehydrogenase type 2 : a novel gene targeting technique

McNairn, Julie Anne January 2018 (has links)
Hypertension is the chronic elevation in blood pressure that is regulated in part through the retention and regulation of sodium retention and excretion in the kidneys. Hence the kidney has been considered the organ that regulates blood pressure. There are a cohort of patients that suffer with high blood pressure due to lack of 11β-hydroxysteroid dehydrogenase-type 2 (11β-HSD2) expression (which inactivates glucocorticoids (GCs), allowing selective activation of mineralocorticoid receptors (MR) by aldosterone) that results in hypertensive and increased salt appetite phenotypes - a condition known as syndrome of apparent mineralocorticoid excess (SAME). This disorder can be recapitulated in the mouse through the global deletion of 11β-HSD2, which results in over activation of the MR driving an elevation in blood pressure. However, the distinction between blood pressure elevation because of kidney dysfunction with loss of 11β-HSD2 or increased salt appetite due to loss of brain 11β-HSD2 expression is not clear from the global 11β-HSD2 knockout model. Salt appetite is regulated by regions of the brain out-with the blood-brain barrier, known as circumventricular organs. In the mouse, salt appetite is controlled by aldosterone-sensitive cells in the nucleus of the solitary tract (NTS) in the brain stem, where 11β-HSD2 is expressed to provide mineralocorticoid selectivity. However, in the fetal brain, 11β-HSD2 is widely expressed, protecting against adverse GC action that alters brain development and increases susceptibility to psychiatric disorders as adults. 11β-HSD2 deletion solely in the brain from embryonic day 12 resulting in GC fetal programming (HSD2BKO) causes effects on both behaviour and salt appetite. To determine the role of developmental versus adult expression of brain 11β- HSD2, mice with deletion of brain 11β-HSD2 from mid gestation (HSD2BKO) and mice with adult deletion of 11β-HSD2 in the NTS using lentivirus (HSD2.v- BKD) were compared. The phenotypes (salt appetite, blood pressure (BP), baroreceptor response (BRR) and cognition), can be categorised as either due to GC fetal programming (as indicated by HSD2BKO groups), or increased activation of MR in adult 11β-HSD2 expressing neurons (recapitulated in the HSD2.v-Cre groups). Salt appetite increased in both HSD2BKO and HSD2.v-BKD cohorts (mean percentage increase 65% n=8 and 46% n=6, compared to their respective controls), leading to an increased BP in both groups (+12% and +8%, respectively) as well as an impaired BRR, indicating all phenotypes are mediated by adult NTS neurons. However, spatial recognition memory (Object-in-Place task) is abolished in HSD2BKO mice, whereas, HSD2.v-BKD mice still retain short-term memory. Our data suggest that neural 11β-HSD2 protects against inappropriate activation of MR by corticosterone to regulate salt appetite and salt-induced rises in blood pressure. However, spatial recognition memory is not influenced by deletion of 11β-HSD2 in the adult brain, confirmation that this phenotype is underpinned by developmental programming by GCs, which is observed in the 11β-HSD2 brain KO. Salt appetite has been shown to be centrally regulated through the adult deletion of 11β-HSD2. From this, our data suggest that an increased salt appetite is due to adult loss of function of 11β-HSD2 rather than GC programming during development. Highlighting the NTS as a region for drug delivery to try and control salt appetite in salt sensitive individuals who struggle with administering a recommended change in diet. To develop this further, minimally invasive modes of delivery of viruses and drugs into the brain were investigated. In so doing, a non-invasive and reversible method to temporarily disrupt the blood brain barrier (BBB) was optimised. The technique required acoustic insonation of ultrasonic contrast agents (CAs) (gas microbubbles) adjacent to the BBB. These microbubbles (SonoVueTM, Bracco) were delivered via tail vein injection into the vasculature. To target the BBB, an ultrasonic transducer was suspended and focused through coupling gel onto the area of interest in the brain with skull the intact. The optimisation of this technique required determination of the focal position of the 3.5MHz transducer that was utilised, in addition to optimisation of the pulse length, pulse repetition frequency and power output of the ultrasound beam to enable the BBB to be disrupted. In addition, measurement of the attenuation of the ultrasound beam through ex vivo mouse skulls were measured. These results showed a 50% reduction in pressure amplitude from the baseline of 335.2mV (Baseline mean = 100% +/-SEM 0 n=3 (No skull), five regions across the skull averaged 47.79% +/-SEM 1.913 n=25 (using 5 different animals). In in vivo mice, after co-injection of the microbubbles with Evans Blue and insonation of the brain, disruption of the BBB was confirmed by the presence of Evans Blue dye in the brain, with no measurable damage occurring in the brain. This was confirmed by cell and nuclear morphology with no red blood cell extravasation into the surrounding tissue. The parameters used to open the BBB used a peak negative pressure of 2.1MPa (single pulse), transducer frequency 3.5MHz, 35,000 cycles over a 10ms burst at a pulse repetition frequency of 10Hz. The technique when applied in vivo in recovery animals is speculated to work by the focused ultrasound causing the microbubbles to oscillate within the vasculature adjacent to the BBB, resulting in high-shear stresses being generated on the tight junctions within the BBB. The resultant gaps in the BBB allow free circulating compounds (e.g. large dye molecules (Evans Blue - 960.8g/mol molecular weight) and adeno-associated-viruses (25nm with a packing capacity of 4.5kb) within the blood to pass into the brain, but there is no penetration of red blood cells (7μm). Longitudinal mouse experiments demonstrated that within 12-hours these gaps close with no long-term damage observed. Currently, utilising this technique, successful passage of an adeno-associated virus expressing GFP (as a marker) has been shown to pass into the brain (n=6 for each cohort including control) - indicating that the virus requires the ultrasound and microbubbles to facilitate its movement into the brain. Further technique optimisation is being explored looking at the role of CAs used in the opening and disruption of the BBB, comparing composition and size of the CAs. Microbubbles (2-3μm) and nanobubbles (200nm) were compared as well as lipid and non-ionic surfactant surface compositions, using volume of drug delivery and degree of disruption as outputs. Using this technique, the hydrophilic drug mimic calcein was delivered into the brain (n=5 non-ionic surfactant nanobubble, n=5 lipid nanobubble). Results have indicated that the delivery of calcein is most efficient when using non-ionic surfactant nanobubbles as opposed to lipid nanobubbles - with a greater volume of the drug being delivered into the cerebral tissue. Furthermore, the concentration and surface composition of the nanobubble have an effect as to the size and potential damage to the brain when opening the BBB. In conclusion, it has been shown that it is possible to non-invasively open the BBB and deliver viruses and dye into the brain. In addition, this thesis has investigated the use of nanobubbles as both facilitators to opening the BBB and delivery vectors for potentially therapeutic drugs. Finally, a non-invasive opening of the BBB has been achieved using focused ultrasound. Ultimately this non-invasive opening of the BBB can be used to achieve delivery of larger molecules (such as antibodies and viruses) into the brain to target treatments. Focused ultrasound brain targeting can be applied to the potential treatment of salt appetite regulation in the NTS. For the individuals who suffer from salt sensitive hypertension, the NTS can be targeted to reduce the drive to ingest high salt diets. Furthermore, the continuation of research into the central control of BP, salt appetite and baroreceptor reflex control can become better understood, using less invasive delivery techniques to the brain.
267

Eml1 in radial glial progenitors during cortical development : the neurodevelopmental role of a protein mutated in subcortical heterotopia in mouse and human / Eml1 dans les progéniteurs de la glie radiaire au cours du développement cortical : rôle d'une protéine mutée dans l'hétérotopie sous-corticale chez la souris et l'humain

Bizzotto, Sara 24 June 2016 (has links)
Le développement du cortex cérébral résulte de processus de prolifération, neurogenèse, migration et différenciation cellulaire qui sont contrôlés génétiquement. Les malformations corticales qui résultent d'anomalies de ces processus sont associées à l'épilepsie et la déficience intellectuelle. Nous avons étudié la souris mutante HeCo (heterotopic cortex), qui présente une hétérotopie sous-cortical bilatérale (neurones présents dans la substance blanche) et nous avons identifié la présence d'une mutation sur le gène Eml1 (Echinoderm Microtubule-associated protein-Like 1). De plus, des mutations du gène EML1 ont été identifiées chez des patients atteints d'une forme sévère et rare d'hétérotopie. Dans le cerveau embryonnaire des souris HeCo, des progéniteurs ont été identifiés en dehors de la zone de prolifération, ce qui représente une nouvelle cause de cette malformation. Nous avons étudié la fonction d'Eml1 dans les progéniteurs de la glie radiaire, qui sont clés au cours de la corticogenèse. Nous avons montré qu'Eml1 se localise dans le fuseau mitotique où elle est susceptible de réguler la dynamique des microtubules. Nos données suggèrent qu'Eml1 peut jouer un rôle dans la régulation de la longueur du fuseau puisque celle-ci est perturbée dans les cellules de la glie radiaire chez la souris HeCo. Ceci pourrait représenter la cause primaire de leur ectopie. Nous avons analysé le nombre et la taille des cellules en métaphase dans la partie apicale de la zone ventriculaire où ont lieu les mitoses. Nous proposons ici de nouveaux mécanismes qui régissent l'organisation des progéniteurs dans la zone ventriculaire au cours du développement cortical normal et pathologique. / The cerebral cortex develops through genetically regulated processes of cellular proliferation, neurogenesis, migration and differentiation. Cortical malformations represent a spectrum of heterogeneous disorders due to abnormalities in these steps, and associated with epilepsy and intellectual disability. We studied the HeCo (heterotopic cortex) mutant mouse, which exhibits bilateral subcortical band heterotopia (SBH), characterized by many aberrantly positioned neurons in the white matter. We found that Eml1 (Echinoderm Microtubule-associated protein-Like 1) is mutated in these mice. Screening of EML1 in heterotopia patients identified mutations giving rise to a severe and rare form of atypical heterotopia. In HeCo embryonic brains, progenitors were identified outside the normal proliferative ventricular zone (VZ), representing a novel cause of this disorder. We studied Eml1 function in radial glial progenitors (RGCs), which are important during corticogenesis generating other subtypes of progenitors and post-mitotic neurons, and serving as guides for migrating neurons. We showed that Eml1 localizes to the mitotic spindle where it might regulate microtubule dynamics. My data suggest a role in the establishment of the steady state metaphase spindle length. Indeed, HeCo RGCs in the VZ showed a perturbed spindle length during corticogenesis, and this may represent one of the primary mechanisms leading to abnormal progenitor behavior. I also analyzed cell number and metaphase cell size at the apical side of the VZ, where mitosis occurs. I thus propose new mechanisms governing normal and pathological VZ progenitor organization and function during cortical development.
268

Avaliação da resposta inflamatória no sistema nervoso central causada pelo herpesvírus equino tipo 1 utilizando um modelo murino de neuroinfecção / Inflammatory response in the central nervous system caused by equine herpesvirus type 1 using a mouse model of neuroinfection

Paloma de Oliveira Tonietti 26 October 2016 (has links)
O herpesvirus equino tipo 1 (EHV-1) é um importante patógeno que causa doença respiratória, abortamento e desordens neurológicas em equinos. O presente estudo foi realizado visando avaliar a resposta inflamatória causada pelo EHV-1 por meio da análise das manifestações clínicas, alterações histopatológicas e resposta imune do hospedeiro no sistema nervoso central (SNC). Camundongos das linhagens BALB/c (H2d), C57BL/6 (H2b) e C3H/HeJ (H2k) foram inoculados por via intranasal com as estirpes brasileiras A4/72 e A9/92 do EHV-1. Nesse estudo, associou-se a histopatologia, a resposta de citocinas pró-inflamatórias no SNC de camundongos das diferentes linhagens e o método de transcrição reversa seguida pela reação em cadeia da polimerase quantitativa em tempo real (RT-qPCR) para investigar a relação entre a infecção pelo EHV-1 e a resposta inflamatória com o desenvolvimento de lesões. As estirpes brasileiras A4/72 e A9/92 do EHV-1 causaram infecção aguda e letal nas diferentes linhagens de camundongos isogênicos. Os sinais clínicos e neurológicos, tais como perda de peso, pelos arrepiados, postura arqueada, apatia, dispneia, desidratação e sialorreia apareceram entre o 2º e 3º dia pós-infecção (dpi). Essas manifestações foram acompanhadas pelo aumento da sensibilidade a estímulos externos, convulsões, recumbência e morte. As alterações histopatológicas consistiram em necrose neuronal, edema, necrose de liquefação, leptomeningite neutrofílica, manguito perivascular, hemorragia focal, inflamação não supurativa, gliose multifocal e infiltração perivascular de células polimorfonucleares e mononucleares. As características e a extensão das lesões variaram entre as linhagens de camundongos. Animais inoculados com a estirpe A4/72 apresentaram lesões histopatológicas de maior grau de severidade quando comparados com aqueles inoculados com a estirpe A9/92. Observou-se aumento da concentração plasmática de TNF-α, IL-6, CCL2 e IFN-γ nos camundongos infectados pelo EHV-1 no 2º dpi. Detectou-se aumento da concentração plasmática e da expressão de mRNA para TNF-α, IL-6 e CCL2 no SNC dos camundongos infectados pelo EHV-1 no 3º dpi; entretanto, não houve aumento da concentração plasmática nem da expressão de mRNA para IFN-γ no 3º dpi. Evidenciou-se que a estirpe A4/72 do EHV-1 induz uma resposta imune sistêmica mais efetiva, enquanto que o vírus A9/92 culmina em uma resposta imunológica mais efetiva no SNC. Os camundongos com o fundo genético C57BL/6 e BALB/c mostraram níveis mais altos de expressão de mRNA para TNF-α, IL-6 e CCL2, quando comparados com os C3H/HeJ. A gravidade dos sinais clínicos observados em camundongos infectados pode ser correlacionada com o pico dessas citocinas pró-inflamatórias (TNF-α e IL-6) e da quimiocina CCL2, que são produzidas logo após a infecção viral por células residentes da glia e/ou infiltrativas no SNC. Esses achados indicam que as diferentes linhagens de camundongos isogênicos são susceptíveis à infecção por estirpes neuropatogênicas do EHV-1; as diferenças no padrão de alterações histopatológicas mostram que elas dependem do hospedeiro infectado, da estirpe viral e da resposta imunológica; e a supressão do interferon (IFN) tipo 1 sugere ser um mecanismo de escape do EHV-1 frente ao sistema imune. A baixa expressão de IL-6, TNF-α e da quimiocina CCL2 em camundongos C3H/HeJ se explica pela mutação no gene toll-like receptor 4 (TLR-4) existente nessa linhagem de camundongo. Adicionalmente, os camundongos C3H/HeJ apresentaram lesões histopatológicas mais severas no SNC quando comparados com BALB/c e C57BL/6. Sugere-se que o IFN tipo I e o gene TLR-4 apresentam importante papel na patogênese do EHV-1 bem como proteínas do agente viral responsáveis pela supressão do IFN e partículas virais que sejam reconhecidas pelo TLR-4 podem ser alvos para o desenvolvimento de novas abordagens para o tratamento da doença viral e para a eficiência de imunógenos / The equine herpesvirus type 1 (EHV-1) is an important pathogen that causes respiratory disease, abortion and neurological disorders in horses. This study was conducted to evaluate the inflammatory response caused by EHV-1 by the analysis of clinical manifestations, histopathological changes and the host immune response in the central nervous system (CNS). BALB/c (H2d), C57BL/6 (H2b) and C3H/HeJ (H2k) mice were inoculated intranasally with Brazilian EHV-1 strains A4/72 and A9/92. In this study, joined histopathology, the response of proinflammatory cytokines in the CNS of mice of different strains and reverse transcription method followed by quantitative polymerase chain reaction in real time (RT-qPCR) to investigate the relationship between infection by EHV-1 and inflammatory response in the development of lesions. Brazilian strains A4/72 and A9/92 EHV-1 caused acute lethal infection in different strains of inbred mice. Clinical and neurological signs such as weight loss, the bristly hair, hunched posture, apathy, dyspnoea, dehydration and salivary hypersecretion appeared between 2nd and 3rd day after infection (dpi). These events were accompanied by increase in the sensitivity to external stimuli, convulsions, recumbency and death. Histopathological changes were neuronal necrosis, edema, liquefaction necrosis, neutrophilic leptomeningitis, perivascular cuff, focal hemorrhage, non-suppurative inflammation, multifocal gliosis and perivascular infiltration of polymorphonuclear and mononuclear cells. The characteristics and the extent of the injuries varied between strains of mice. Animals inoculated with the A4/72 strain showed histopathological lesions of greater severity when compared with those inoculated with the A9/92 strain. There was an increase in plasma concentrations of TNF-α, IL-6, CCL2 and IFN-γ in mice infected by EHV-1 in 2nd dpi. Plasma concentrations and the expression of mRNA for TNF-α, IL-6 and CCL2 in the CNS of mice infected with EHV-1 at 3rd dpi were increased; however, there was no increase in plasma concentration or expression for the mRNA of IFN-γ at 3rd dpi. It was evident that the EHV-1 strain A4/72 induces a more effective systemic immune response, whereas the A9/92 virus culminates in a more effective immune response in the CNS. The C57BL/6 and BALB/c mice showed higher levels of mRNA expression for TNF-α, IL-6 and CCL2, compared to C3H/HeJ mice. The severity of clinical signs observed in infected mice can be correlated with the peak of these proinflammatory cytokines (TNF-α and IL-6) and CCL2 chemokine, which are then produced after viral infection by resident glial cells and/or infiltrative cells in the CNS. These findings indicate that different strains of inbred mice are susceptible to infection neuropathogenic EHV-1 strains; the differences in the pattern of pathological changes show that they depend on the infected host, the EHV-1 strain and the immune response; and the suppression of interferon (IFN) type I suggested to be an escape mechanism for the EHV-1 against the immune system. The low expression of IL-6, TNF-α and chemokine CCL2 in C3H/HeJ mice can be explained by a mutation in toll-like receptor 4 (TLR-4) gene existing in this mouse strain. Additionally, C3H/HeJ mice exhibited more severe histopathological lesions in the CNS as compared to BALB/c and C57BL/6. It is suggested that type I IFN and TLR-4 gene have important role in the pathogenesis of EHV-1 and viral agent proteins responsible for the suppression of IFN and the viral particles that are recognized by TLR-4 can be targets for the development of new approaches for the treatment of viral disease and the efficiency of immunogens
269

Die Rolle von ICOS für die T-Zell-Effektorfunktion in vivo

Burmeister, Yvonne 27 April 2009 (has links)
Der Induzierbare Kostimulator (ICOS) ist ein wichtiger Regulator der T-Zell-Effektorfunktion. In vivo führt ein Defekt von ICOS zur Beeinträchtigung der T-Zellabhängigen humoralen Immunität. In gendefizienten Mäusen wurden stark gestörte B-Zellantworten beobachtet. Mehrere in vitro und in vivo Studien führen diese Phänomene auf eine beeinträchtigte Regulation von Kommunikationsmolekülen auf der Zelloberfläche und Expression von Zytokinen durch ICOS-defiziente T-Zellen zurück. In dieser Arbeit konnte jedoch anhand Antigen-spezifischer T-Zellen in einem murinen adoptiven Transfersystem gezeigt werden, dass das Signal über ICOS die frühe T-Zellaktivierung nicht signifikant beeinflusst. Stattdessen trägt ICOS wesentlich zum Überleben und zur Expansion von Effektor T-Zellen bei, die zuvor lokal durch Antigengabe mit Adjuvanz induziert wurden. Diese beobachtete biologische Funktion von ICOS lässt sich auch auf FoxP3+ Regulatorische T-Zellen übertragen, welche durch systemische Antigengabe ohne Adjuvanz generiert wurden. In Übereinstimmung mit diesem Befund führt die Abwesenheit von ICOS unter homöostatischen Bedingungen in nicht-immunisierten Mäusen zu reduzierten Zellzahlen von Effektor-Memory T-Zellen und FoxP3+ Regulatorischen T-Zellen. Der regulierende Effekt von ICOS auf die Größe einer spezifischen Effektor T-Zellpopulation gilt auch für Follikuläre T-Helferzellen, konnte jedoch für zytotoxische CD8+ T-Zellen nicht eindeutig nachgewiesen werden. Auf der Grundlage dieser Ergebnisse kristallisiert sich eine globale biologische Rolle von ICOS für Effektorzellen heraus. Als kostimulatorisches, agonistisches Molekül reguliert ICOS generell die Pool-Größe aller Effektor T-Zellen mit unterschiedlichen, teilweise gegensätzlichen funktionellen Eigenschaften. Mit Hilfe dieses neuen Konzeptes können frühere in vivo Studien, deren Ergebnisse in Bezug auf die Funktion von ICOS scheinbar widersprüchlich waren, in Einklang gebracht werden. / The Inducible Co-Stimulator (ICOS) is an important regulator of T cell effector function. In vivo ICOS deficiency results in impaired T-cell dependent humoral immunity. Knock out mice show strongly defective B cell responses. Several in vitro and in vivo studies attributed this phenomenon to impaired upregulation of cell surface communication molecules and cytokine synthesis by ICOS-deficient T cells. However, in this work now could be shown with antigen-specific T cells in a murine adoptive transfer system that signaling via ICOS does not significantly affect early T cell activation. Instead, ICOS substantially contributes to the survival and expansion of effector T cells upon local challenge with antigen and adjuvant. Importantly, the observed biological function of ICOS also extends to FoxP3+ regulatory T cells, as can be observed after systemic antigen delivery without adjuvant. In line with these findings, absence of ICOS under homeostatic conditions of nonimmunized mice leads to a reduced number of both effector-memory and FoxP3+ regulatory T cells. The regulatory function of ICOS to control the poolsize of special T cell effector populations is also observed for follicular B helper T cells. The influence of ICOS on cytotoxic CD8+ T cells could not be clearly demonstrated. Based on these results, I propose a biological role for ICOS as a costimulatory, agonistic molecule for a variety of effector T cells with differing and partly opposing funtional roles. This concept may reconcile a number of past in vivo studies with seemingly cotradictory results on ICOS function.
270

Konstruktion und Charakterisierung transgener Mauslinien für humane Sulfotransferasen als Modellsysteme für eine SULT-vermittelte metabolische Aktivierung / Construction and characterisation of transgenic mouse lines for human sulfotransferases as model systems for a SULT-mediated metabolic activation

Dobbernack, Gisela January 2008 (has links)
Die Enzyme der Sulfotransferase-Gensuperfamilie (SULT) konjugieren nukleophile Gruppen von kleinen endogenen Verbindungen und Fremdstoffen mit der negativ geladenen Sulfo-Gruppe. Dadurch wird die Polarität dieser Verbindungen erhöht, ihre passive Permeation von Zellmembranen verhindert und somit ihre Ausscheidung erleichtert. Jedoch stellt die Sulfo-Gruppe in bestimmten chemischen Verbindungen eine gute Abgangsgruppen dar. Aus der Spaltung resultierende Carbenium- oder Nitreniumionen können mit DNA oder anderen zellulären Nukleophilen reagieren. In Testsystemen für Mutagenität wurden zahlreiche Verbindungen, darunter Nahrungsinhaltsstoffe und Umweltkontaminanten, durch SULT zu Mutagenen aktiviert. Dabei zeigten sich zum einen eine ausgeprägte Substratspezifität selbst orthologer SULT-Formen unterschiedlicher Spezies und zum anderen Interspezies-Unterschiede in der SULT-Gewebeverteilung. Daher könnten sich die Zielgewebe einer SULT-induzierten Krebsentstehung bei Mensch und Nager unterscheiden. Um die Beteiligung von humanen SULT an der Bioaktivierung von Fremdstoffen im Tiermodell untersuchen zu können, wurden transgene Mauslinien für den Cluster der humanen SULT1A1- und -1A2-Gene sowie für die humane SULT1B1 generiert. Zur Herstellung der transgenen Linien wurden große genomische Konstrukte verwendet, die die SULT-Gene sowie – zum Erreichen einer der Humansituation entsprechenden Gewebeverteilung der Proteinexpression – deren potentielle regulatorische Sequenzen enthielten. Es wurden je drei transgene Linien für hSULT1A1/hSULT1A2 und drei transgene Linien für hSULT1B1 etabliert. Die Expression der humanen Proteine konnte in allen Linien gezeigt werden und fünf der sechs Linien konnten zur Homozygotie bezüglich der Transgene gezüchtet werden. In der molekularbiologischen Charakterisierung der transgenen Linien wurde der chromosomale Integrationsort der Konstrukte bestimmt und die Kopienzahl pro Genom untersucht. Mit Ausnahme einer hSULT1A1/hSULT1A2-transgenen Linie, bei der Kopien des Konstrukts in zwei unterschiedliche Chromosomen integriert vorliegen, wiesen alle Linien nur einen Transgen-Integrationsort auf. Die Untersuchung der Transgen-Kopienzahl ergab, dass die Mauslinien zwischen einer und etwa 20 Kopien des Transgen-Konstrukts pro Genom trugen. In der proteinbiochemischen Charakterisierung wurde gezeigt, dass die transgenen Linien die humanen Proteine mit einer weitgehend der des Menschen entsprechenden Gewebeverteilung exprimieren. Die Intensität der im Immunblot nachgewiesenen Expression korrelierte mit der Kopienzahl der Transgene. Die zelluläre und subzelluläre Verteilung der Transgen-Expression wurden bei einer der hSULT1A1/hSULT1A2-transgenen Linien in Leber, Niere, Lunge, Pankreas, Dünndarm und Kolon und bei einer der hSULT1B1-transgenen Linien im Kolon untersucht. Sie stimmte ebenfalls mit der Verteilung der entsprechenden SULT-Formen im Menschen überein. Da sich die erzeugten transgenen Linien aufgrund ihrer mit dem Menschen vergleichbaren Gewebeverteilung der SULT-Expression als Modellsystem zur Untersuchung der menschlichen SULT-vermittelten metabolischen Aktivierung eigneten, wurde eine der hSULT1A1/hSULT1A2-transgenen Linien für zwei erste toxikologische Untersuchungen eingesetzt. Den Mäusen wurden chemische Verbindungen verabreicht, für die in in-vitro-Versuchen eine hSULT1A1/hSULT1A2-vermittelte Bioaktivierung zu Mutagenen gezeigt worden war. In beiden Untersuchungen wurde die Gewebeverteilung der entstandenen DNA-Addukte als Endpunkt einer gewebespezifischen genotoxischen Wirkung ermittelt. In der ersten Untersuchung wurden 90 mg/kg Körpergewicht 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridin – ein in gebratenem Fleisch gebildetes heterozyklisches aromatisches Amin – transgenen sowie Wildtyp-Mäusen oral verabreicht. Acht Stunden nach Applikation wiesen die transgenen Mäuse signifikant höhere Adduktniveaus als die Wildtyp-Mäuse in Leber, Lunge, Niere, Milz und Kolon auf. In der Leber der transgen Mäuse war das Adduktniveau 17fach höher als in der Leber der Wildtyp-Mäuse. Die Leber war bei den transgenen Tieren das Organ mit dem höchsten, bei den Wildtyp-Tieren hingegen mit dem niedrigsten DNA-Adduktniveau. In der zweiten Untersuchung (Pilotstudie mit geringer Tierzahl) wurde transgenen und Wildtyp-Mäusen 19 mg/kg Körpergewicht des polyzyklischen aromatischen Kohlenwasserstoffs 1-Hydroxymethylpyren – ein Metabolit der Nahrungs- und Umweltkontaminante 1-Methylpyren – intraperitoneal verabreicht. Nach 30 Minuten wurden, verglichen mit den Wildtyp-Mäusen, bis zu 25fach erhöhte Adduktniveaus bei den transgenen Mäusen in Leber, Niere, Lunge und Jejunum nachgewiesen. Somit konnte anhand einer in dieser Arbeit generierten transgenen Mauslinie erstmals gezeigt werden, dass die Expression der humanen SULT1A1/hSULT1A2 tatsächlich sowohl auf die Stärke als auch die Zielgewebe der DNA-Adduktbildung in vivo eine Auswirkung hat. / The enzymes of the sulfotransferase gene superfamily (SULT) conjugate nucleophilic groups of small endogenous compounds and xenobiotics with the negatively charged sulfo group. Thus, the polarity of the compounds is increased, their passive permeation of cell membranes is hindered and their excretion facilitated. The sulfate groups, however, form a good leaving group in certain chemical linkages due to their electron-withdrawing characteristics. Carbenium or nitrenium ions resulting from a spontaneous cleavage may react with DNA and other cellular nucleophiles. In test systems for mutagenicity, a large amount of compounds including ingredients of nutrition and environmental contaminants were activated to mutagens by SULT. A pronounced substrate specificity even of orthologous SULT forms of different species was evidenced. Also, the tissue distribution of SULT exhibited pronounced interspecies differences. The target tissues of a SULT induced carcinogenesis might thus be different in humans and rodents. To investigate the involvement of human SULT in the bioactivation of xenobiotics in an animal model, transgenic mouse lines for the human SULT1A1- and -1A2 gene cluster as well as for human SULT1B1 were generated. For the construction of the transgenic lines, large genomic constructs were used, containing the SULT genes plus their potential regulatory sequences to cause a tissue distribution of protein expression corresponding to the situation in humans. Three transgenic lines for hSULT1A1/hSULT1A2 and three transgenic lines for hSULT1B1 were established. The expression of the human proteins could be shown for all lines and except for one line, all could be bred to transgene homozygosity. By molecular biological characterization of the transgenic lines, the chromosomal integration locus of the constructs was identified and the copy number per genome was investigated. With the exception of one hSULT1A1/hSULT1A2 transgenic line, where the construct had integrated into two different chromosomes, all lines exhibited just one transgene integration locus. By investigating the transgene copy number it was deduced that the mouse lines carry between one and 20 copies of the transgene construct per genome. The protein biochemical characterization showed that the transgenic mouse lines express the human proteins with a tissue distribution largely similar to the distribution in humans. The intensity of the proteins detected by immunoblotting correlated with the copy number of the transgenes. The cellular and subcellular distribution of the transgene expression was investigated for one of the hSULT1A1/1A2 transgenic lines in liver, kidney, lung, pancreas, small intestine and colon and for one of the hSULT1B1 transgenic lines in colon. It also accorded with the distribution of the respective SULT in humans. Owing to the similarity of transgene expression to the corresponding human tissue distribution, the transgenic lines were considered suitable as model systems for the investigation of the human SULT-mediated metabolic activation. One of the hSULT1A1/hSULT1A2 transgenic lines was used in two first toxicological investigations with chemical compounds for which in vitro experiments had demonstrated a hSULT1A1/hSULT1A2 mediated bioactivation. In both investigations, the tissue distribution of the resulting DNA adducts was determined as an end point for a tissue-specific genotoxic effect. For the first investigation, 90 mg/kg bodyweight of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine – a heterocyclic amine formed in cooked meat – were orally administered to transgenic and wild type mice. Eight hours after application, the transgenic mice exhibited significantly higher adduct levels than the wild type controls in liver, lung, kidney, spleen and colon. The adduct level in the liver of the transgenic mice exceeded that in the wild type liver by a factor of 17. Furthermore, the liver was the organ with the highest adduct level in the transgenic mice and with the lowest adduct level in the wild type mice. For the second investigation (a pilot study with few animals), 19 mg/kg bodyweight of the polycyclic aromatic hydrocarbon 1-hydroxymethylpyrene – a metabolite of the nutritional and environmental contaminant 1-methylpyrene – were administered intraperitoneally to transgenic and wild type mice. After 30 minutes, up to 25 fold higher adduct levels compared to the wild type were detected in liver, kidney, lung and jejunum of the transgenic mice. Thus, by means of one of the transgenic mouse line generated in this thesis, it could be shown for the first time that the expression of human SULT1A1/SULT1A2 has in fact an impact on the strength as well as on the target tissue of DNA-adduct generation in vivo.

Page generated in 0.0865 seconds